BioLineRx (BLRX) Change in Inventory (2023 - 2026)
BioLineRx (BLRX) posted quarterly Change in Inventory of $33000.0 for Q4 2025, down 91.73% year-over-year from $399000.0 in Q4 2024, and down 95.07% quarter-over-quarter from $669000.0 in Q3 2025.
Powered by 
Analysis
BioLineRx (BLRX) Change in Inventory (2023 - 2026) Analysis & Trends
BioLineRx's Change in Inventory history runs 3 years deep, the most recent figure standing at $33000.0 for Q4 2025.
- In Q4 2025, Change in Inventory fell 91.73% year-over-year to $33000.0; the TTM figure through Dec 2025 stood at $997000.0 (up 183.64% YoY), while the FY2025 annual figure was $997000.0, up 183.64% from the prior year.
- Change in Inventory for Q4 2025 stood at $33000.0, down from $669000.0 in the prior quarter.
- The five-year high for Change in Inventory was $669000.0 in Q3 2025, with the low at -$1.4 million in Q3 2023.
- The 3-year median for Change in Inventory is -$68500.0 (2025), against an average of -$214800.0.
- Peak annual rise in Change in Inventory reached 643.33% in 2025, while the deepest fall reached 91.73% in 2025.
- BioLineRx's Change in Inventory stood at -$601000.0 in 2023, then jumped by 166.39% to $399000.0 in 2024, then slumped by 91.73% to $33000.0 in 2025.
- Business Quant data shows BLRX's Change in Inventory at $33000.0 in Q4 2025, $669000.0 in Q3 2025, and $465000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | BioLineRx | 6.64 Bn | 6.64 Bn | 235,000.00 | -10,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10,000.00 |
| Mar 31, 2026 | -9,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 669,000.00 |
| Jun 30, 2025 | 465,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | 399,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | -745,000.00 |
| Mar 31, 2024 | -936,000.00 |
| Dec 31, 2023 | -601,000.00 |
| Sep 30, 2023 | -1.35 Mn |